National and Kapodistrian University of Athens
Αναζήτηση του είδους και της συχνότητας των μοριακών διαταραχών του γονιδίου CYP21A2 ( ΣΥΕ ) στο γενικό πληθυσμό, σε διάφορες περιοχές της Ελλάδος: δημιουργία βάσης δεδομένων για εφαρμογή εξέτασης διαλογής για ΣΥΕ ( screening ) στον ελληνικό πληθυσμό
Abstract
dc:descriptionDefective steroidogenesis caused by mutations of the 21-hydroxylase gene (CYP21Α2), is the most common cause of congenital adrenal hyperplasia (CAH), covering about 95% of cases of CAH. Data on the gene frequency based on molecular studies are scarce. AIM OF THE STUDY The aim of our study was to determine the CYP21Α2 gene defects, their frequencies and the geographic distribution in the Hellenic population, a finding of theoretical and practical importance for genetic counseling. SUBJECTS AND METHODS Blood samples from unrelated neonates were obtained from maternity hospitals around Greece, during the period 2002-2004. DNA analysis has been carried out in 908 chromosomes. Allele-specific PCR was employed to identify 12 molecular defects of the CYP21A2 gene: homozygous deletion/conversion, P30L and W22X (exon1), I2spice (intron 2), 8bpdE3 (exon3), I172N (exon4), ClusterE6 (exon6), V281L and F306+T (exon7), Q318X and R356W (exon8), P453S (exon10) and two polymorfisms ( K102R, S268T ). We have previously shown that these mutations account for 97% of CYP21A2 defects in Greek patient population. RESULTS 47 mutant alleles (5.2%) were detected, all in the heterozygous state. 15 mutant alleles (1.6%) carried mutations associated with the classical (C) form of 21-hydroxylase deficiency; 11 Q318X (1,2%), 2 I172N (0,22%), 1 Ι2splice (0,11%), 1 W22X (0,11%). 32 mutant alleles (3.5%) carried mutations concordant with the non classical (NC) form of the disease; 19 V281L (2.1%), 9 P453S (0.99%) and 4 P30L (0.44%). 9.9% of our subjects were found to be carriers of molecular defects of 21-hydroxylase deficiency. The heterozygote frequency for C form was 3.1% and for NC forms 6.8%. We estimated in the Hellenic population the incidence for the NC form is 1:416 and for C form 1:3,3663. The calculated gene frequency is 0.052. CONCLUSIONS We confirmed that previous findings based on hormonal newborn screening appear inaccurate and underestimate the frequency of CAH. We 106 concluded that gene frequency varies significantly in the different populations and cannot be extrapolated from data in some population groups. The findings of our study can be applied i) to create a data base for establishing a neonatal screening program in the Greek population, ii) to orientate the molecular analysis of a patient, iii) to early recognize of the affected fetus during prenatal control, a finding needed for preventing virilization of the female fetus, and iv) to detect heterozygotes in the general population, a prerequisite for genetic counseling.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dastamani, Antonia
- Δασταμάνη, Αντωνία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23628